Monitor next earnings call for any catalyst that might explain the concentrated buying by Assenagon and the smaller adds by three asset managers. The absence of insider buying reduces conviction in the signal.
ERAS drugs
ERAS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $14.64entry
- T+1 · 13d ago +1.84%α +0.19% · $14.91
- T+5 · 7d ago +5.74%α +6.33% · $15.48
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Four institutional investors increased their positions in Erasca during Q3 2026, with Assenagon Asset Management more than quadrupling its stake to $60.5M, accounting for the bulk of the $46.3M net buying. No insiders bought shares in the same period, and the 13F data is 45+ days stale, weakening the signal.
Key Financial Metrics
Institutional Positions
Net institutional flow: $46.3M
▲ Buyers (4)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | DOUBLED | +407.9% | $60.5M | $45.6M |
| Strs Ohio | ADD | +95.3% | $1.2M | $440.0K |
| Principal Financial Group | DOUBLED | +103.6% | $457.0K | $176.0K |
| Mirae Asset Global Investments Co. | ADD | +28.5% | $262.0K | $7.0K |
Key Facts
- 4 institutional buyers, 0 sellers in Q3 2026
- Aggregate net buying of $46.3M across 4 funds
- Assenagon Asset Management doubled its position by 407.9% to $60.5M
- No insider open-market buying (confluence score 24/100, institutions-only)
- 13F data reflects quarter-end positions, now at least 45 days old
Financial Impact
Net institutional buying of $46.3M, representing approximately 0.9% of the $5.2B market cap
Risk Factors
- 13F data is stale (45+ day lag); positions may have been unwound since quarter-end
- No insider corroboration, the cluster is institutions-only
- Three of four buyers are small adds; the signal is heavily driven by one fund (Assenagon)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ERAS-2026-Q3 |
Track record
26 reports on ERAS
4 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +95.35% at T+60 after the Apr 27, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $15.21 settles Feb 12
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.31 settles Feb 12
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.35 settles Feb 12
- Nov 12, 20264d ago Press Release Neutral 4/10 Entry $15.66 settles Feb 11
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Viewing Entry $14.64 settles Feb 1
- Oct 16, 20264w ago 8-K Neutral 2/10 Entry $13.39 settles Jan 13
- Aug 24, 202612w ago 8-K Bullish 5/10 Entry $17.60 settles Nov 17
- Aug 17, 202613w ago 144 Neutral 3/10 Entry $18.28 to $15.61 ▼ −14.61% −11.84% vs SPY
- Aug 13, 202613w ago Institutional Cluster Bullish 6/10 Entry $17.86 to $14.41 ▼ −19.32% −13.84% vs SPY
- Aug 12, 202613w ago 3 Neutral 2/10 Entry $17.86 to $14.41 ▼ −19.32% −13.84% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers